Skip to main content Back to Top
Advertisement

7/22/2024

Amphetamine Mixed Salts, Immediate-Release Tablets

Products Affected - Description

    • Amphetamine mixed salts immediate release tablet, Camber, 10 mg, bottle, 100 count, NDC 31722-0157-01 - discontinued
    • Amphetamine mixed salts immediate release tablet, Camber, 12.5 mg, bottle, 100 count, NDC 31722-0158-01 - discontinued
    • Amphetamine mixed salts immediate release tablet, Camber, 15 mg, bottle, 100 count, NDC 31722-0159-01 - discontinued
    • Amphetamine mixed salts immediate release tablet, Camber, 20 mg, bottle, 100 count, NDC 31722-0163-01 - discontinued
    • Amphetamine mixed salts immediate release tablet, Camber, 30 mg, bottle, 100 count, NDC 31722-0164-01 - discontinued
    • Amphetamine mixed salts immediate release tablet, Camber, 5 mg, bottle, 100 count, NDC 31722-0155-01 - discontinued
    • Amphetamine mixed salts immediate release tablet, Camber, 7.5 mg, bottle, 100 count, NDC 31722-0156-01 - discontinued
    • Amphetamine mixed salts immediate release tablet, Granules, 12.5 mg, bottle, 100 count, NDC 70010-0114-01
    • Amphetamine mixed salts immediate release tablet, Granules, 7.5 mg, bottle, 100 count, NDC 70010-0112-01
    • Amphetamine mixed salts immediate release tablet, Mallinckrodt, 10 mg, bottle, 100 count, NDC 00406-8892-01
    • Amphetamine mixed salts immediate release tablet, Mallinckrodt, 15 mg, bottle, 100 count, NDC 00406-8885-01
    • Amphetamine mixed salts immediate release tablet, Mallinckrodt, 20 mg, bottle, 100 count, NDC 00406-8893-01
    • Amphetamine mixed salts immediate release tablet, Mallinckrodt, 30 mg, bottle, 100 count, NDC 00406-8894-01
    • Amphetamine mixed salts immediate release tablet, Mallinckrodt, 7.5 mg, bottle, 100 count, NDC 00406-8884-01
    • Amphetamine mixed salts immediate release tablet, Rhodes, 10 mg, bottle, 100 count, NDC 42858-0723-01
    • Amphetamine mixed salts immediate release tablet, Rhodes, 12.5 mg, bottle, 100 count, NDC 42858-0724-01
    • Amphetamine mixed salts immediate release tablet, Rhodes, 15 mg, bottle, 100 count, NDC 42858-0725-01
    • Amphetamine mixed salts immediate release tablet, Rhodes, 20 mg, bottle, 100 count, NDC 42858-0726-01
    • Amphetamine mixed salts immediate release tablet, Rhodes, 30 mg, bottle, 100 count, NDC 42858-0727-01
    • Amphetamine mixed salts immediate release tablet, Rhodes, 5 mg, bottle, 100 count, NDC 42858-0721-01
    • Amphetamine mixed salts immediate release tablet, Rhodes, 7.5 mg, bottle, 100 count, NDC 42858-0722-01
    • Amphetamine mixed salts immediate release tablet, Sandoz, 5 mg, bottle, 100 count, NDC 00185-2098-01
    • Amphetamine mixed salts immediate release tablet, Solco Healthcare US, 10 mg, bottle, 100 count, NDC 43547-0458-10 - discontinued
    • Amphetamine mixed salts immediate release tablet, Solco Healthcare US, 5 mg, bottle, 100 count, NDC 43547-0457-10 - discontinued
    • Amphetamine mixed salts immediate release tablet, Teva, 30 mg, bottle, 100 count, NDC 00555-0974-02
    • Amphetamine mixed salts immediate release tablet, Teva, 5 mg, bottle, 100 count, NDC 00555-0971-02

Reason for the Shortage

    • Alvogen has all presentations available to contracted customers.
    • Aurobindo refuses to provide availability information.
    • Camber discontinued amphetamine mixed salts immediate-release tablets.
    • Elite Laboratories has amphetamine mixed salts immediate-release tablets available.
    • Epic Pharma has amphetamine mixed salts immediate-release tablets available.
    • Granules states the shortage is due to shortage of active ingredient.
    • Lannett has amphetamine mixed salts immediate-release tablets available.
    • Mallinckrodt has product on shortage due to shortage of active ingredient.
    • Oryza Pharmaceuticals (US Pharma) has amphetamine mixed salts immediate-release tablets available.
    • Rhodes did not provide a reason for the shortage.
    • Sandoz has amphetamine mixed salts immediate-release tablets available.
    • Solco discontinued amphetamine mixed salts immediate-release tablets.
    • Sunrise has amphetamine mixed salts immediate-release tablets available.
    • Teva has Adderall and the generics on shortage due to increased demand.
    • Mylan and Zydus have discontinued amphetamine mixed salt immediate-release tablets.

Available Products

    • Adderall immediate release tablet, Teva, 10 mg, bottle, 100 count, NDC 57844-0110-01
    • Adderall immediate release tablet, Teva, 12.5 mg, bottle, 100 count, NDC 57844-0112-01
    • Adderall immediate release tablet, Teva, 15 mg, bottle, 100 count, NDC 57844-0115-01
    • Adderall immediate release tablet, Teva, 20 mg, bottle, 100 count, NDC 57844-0120-01
    • Adderall immediate release tablet, Teva, 30 mg, bottle, 100 count, NDC 57844-0130-01
    • Adderall immediate release tablet, Teva, 5 mg, bottle, 100 count, NDC 57844-0105-01
    • Adderall immediate release tablet, Teva, 7.5 mg, bottle, 100 count, NDC 57844-0117-01
    • Amphetamine mixed salts immediate release tablet, Alvogen, 10 mg, bottle, 100 count, NDC 47781-0176-01
    • Amphetamine mixed salts immediate release tablet, Alvogen, 15 mg, bottle, 100 count, NDC 47781-0178-01
    • Amphetamine mixed salts immediate release tablet, Alvogen, 20 mg, bottle, 100 count, NDC 47781-0179-01
    • Amphetamine mixed salts immediate release tablet, Alvogen, 30 mg, bottle, 100 count, NDC 47781-0180-01
    • Amphetamine mixed salts immediate release tablet, Alvogen, 5 mg, bottle, 100 count, NDC 47781-0174-01
    • Amphetamine mixed salts immediate release tablet, Elite Laboratories, 10 mg, bottle, 100 count, NDC 64850-0502-01
    • Amphetamine mixed salts immediate release tablet, Elite Laboratories, 12.5 mg, bottle, 100 count, NDC 64850-0503-01
    • Amphetamine mixed salts immediate release tablet, Elite Laboratories, 15 mg, bottle, 100 count, NDC 64850-0504-01
    • Amphetamine mixed salts immediate release tablet, Elite Laboratories, 20 mg, bottle, 100 count, NDC 64850-0505-01
    • Amphetamine mixed salts immediate release tablet, Elite Laboratories, 30 mg, bottle, 100 count, NDC 64850-0506-01
    • Amphetamine mixed salts immediate release tablet, Elite Laboratories, 5 mg, bottle, 100 count, NDC 64850-0500-01
    • Amphetamine mixed salts immediate release tablet, Elite Laboratories, 7.5 mg, bottle, 100 count, NDC 64850-0501-01
    • Amphetamine mixed salts immediate release tablet, Epic Pharma, 10 mg, bottle, 100 count, NDC 42806-0341-01
    • Amphetamine mixed salts immediate release tablet, Epic Pharma, 15 mg, bottle, 100 count, NDC 42806-0343-01
    • Amphetamine mixed salts immediate release tablet, Epic Pharma, 20 mg, bottle, 100 count, NDC 42806-0344-01
    • Amphetamine mixed salts immediate release tablet, Epic Pharma, 30 mg, bottle, 100 count, NDC 42806-0345-01
    • Amphetamine mixed salts immediate release tablet, Epic Pharma, 5 mg, bottle, 100 count, NDC 42806-0339-01
    • Amphetamine mixed salts immediate release tablet, Granules, 10 mg, bottle, 100 count, NDC 70010-0113-01
    • Amphetamine mixed salts immediate release tablet, Granules, 15 mg, bottle, 100 count, NDC 70010-0115-01
    • Amphetamine mixed salts immediate release tablet, Granules, 20 mg, bottle, 100 count, NDC 70010-0116-01
    • Amphetamine mixed salts immediate release tablet, Granules, 30 mg, bottle, 100 count, NDC 70010-0117-01
    • Amphetamine mixed salts immediate release tablet, Granules, 5 mg, bottle, 100 count, NDC 70010-0111-01
    • Amphetamine mixed salts immediate release tablet, Lannett, 10 mg, bottle, 100 count, NDC 00527-0762-37
    • Amphetamine mixed salts immediate release tablet, Lannett, 12.5 mg, bottle, 100 count, NDC 00527-0763-37
    • Amphetamine mixed salts immediate release tablet, Lannett, 15 mg, bottle, 100 count, NDC 00527-0764-37
    • Amphetamine mixed salts immediate release tablet, Lannett, 20 mg, bottle, 100 count, NDC 00527-0765-37
    • Amphetamine mixed salts immediate release tablet, Lannett, 30 mg, bottle, 100 count, NDC 00527-0766-37
    • Amphetamine mixed salts immediate release tablet, Lannett, 5 mg, bottle, 100 count, NDC 00527-0760-37
    • Amphetamine mixed salts immediate release tablet, Lannett, 7.5 mg, bottle, 100 count, NDC 00527-0761-37
    • Amphetamine mixed salts immediate release tablet, Mallinckrodt, 5 mg, bottle, 100 count, NDC 00406-8891-01
    • Amphetamine mixed salts immediate release tablet, Oryza Pharmaceuticals, 10 mg, bottle, 100 count, NDC 72516-0014-01
    • Amphetamine mixed salts immediate release tablet, Oryza Pharmaceuticals, 15 mg, bottle, 100 count, NDC 72516-0013-01
    • Amphetamine mixed salts immediate release tablet, Oryza Pharmaceuticals, 20 mg, bottle, 100 count, NDC 72516-0012-01
    • Amphetamine mixed salts immediate release tablet, Oryza Pharmaceuticals, 30 mg, bottle, 100 count, NDC 72516-0011-01
    • Amphetamine mixed salts immediate release tablet, Oryza Pharmaceuticals, 5 mg, bottle, 100 count, NDC 72516-0016-01
    • Amphetamine mixed salts immediate release tablet, Sandoz, 10 mg, bottle, 100 count, NDC 00185-0842-01
    • Amphetamine mixed salts immediate release tablet, Sandoz, 20 mg, bottle, 100 count, NDC 00185-0853-01
    • Amphetamine mixed salts immediate release tablet, Sandoz, 30 mg, bottle, 100 count, NDC 00185-2099-01
    • Amphetamine mixed salts immediate release tablet, Sunrise, 10 mg, bottle, 100 count, NDC 11534-0192-01
    • Amphetamine mixed salts immediate release tablet, Sunrise, 12.5 mg, bottle, 100 count, NDC 11534-0193-01
    • Amphetamine mixed salts immediate release tablet, Sunrise, 15 mg, bottle, 100 count, NDC 11534-0194-01
    • Amphetamine mixed salts immediate release tablet, Sunrise, 20 mg, bottle, 100 count, NDC 11534-0195-01
    • Amphetamine mixed salts immediate release tablet, Sunrise, 30 mg, bottle, 100 count, NDC 11534-0196-01
    • Amphetamine mixed salts immediate release tablet, Sunrise, 5 mg, bottle, 100 count, NDC 11534-0190-01
    • Amphetamine mixed salts immediate release tablet, Sunrise, 7.5 mg, bottle, 100 count, NDC 11534-0191-01
    • Amphetamine mixed salts immediate release tablet, Teva, 10 mg, bottle, 100 count, NDC 00555-0972-02
    • Amphetamine mixed salts immediate release tablet, Teva, 12.5 mg, bottle, 100 count, NDC 00555-0776-02
    • Amphetamine mixed salts immediate release tablet, Teva, 15 mg, bottle, 100 count, NDC 00555-0777-02
    • Amphetamine mixed salts immediate release tablet, Teva, 20 mg, bottle, 100 count, NDC 00555-0973-02
    • Amphetamine mixed salts immediate release tablet, Teva, 7.5 mg, bottle, 100 count, NDC 00555-0775-02

Estimated Resupply Dates

    • Granules has amphetamine mixed salts 7.5 mg and 12.5 mg immediate-release tablets on back order and the company estimates a release date of July 2024.
    • Mallinckrodt has most amphetamine mixed salts tablets on intermittent back order and the company is releasing supplies as they become available.
    • Rhodes has all presentations on back order and the company cannot estimate a release date.
    • Sandoz has amphetamine mixed salts 5 mg immediate-release tablets on back order and the company cannot estimate a release date. Short-dated product is available.
    • Teva has amphetamine mixed salts 5 mg and 30 mg immediate-release tablets on back order and the company estimates a release date of early-August 2024.

Safety

    • The CDC has issued a health advisory regarding potential disrupted access to prescription stimulant medications and possible increased risks for injury and overdose. The health advisory can be found at https://emergency.cdc.gov/han/2024/han00510.asp

Updated

Updated July 22, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created July 27, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT